Related Experiment Videos
Transient ischaemic attacks : new approaches to management.
Ramesh Madhavan1, Seemant Chaturvedi
1Department of Neurology and Comprehensive Stroke Program, Wayne State University/Detroit Medical Center, Detroit, Michigan 48201, USA.
CNS Drugs
|April 1, 2003
Summary
Transient ischemic attacks (TIAs) are recognized stroke precursors. Modern management involves complex pharmacological approaches, including newer antiplatelet agents and combination therapies for stroke prevention.
Area of Science:
- Neurology
- Vascular Neurology
- Cerebrovascular Disease
Background:
- Transient ischemic attacks (TIAs) have long been recognized as precursors to ischemic stroke.
- Recent research challenges traditional views on TIAs as distinct entities and their prognosis.
- Evolving clinical trials reveal increased complexity in TIA management.
Purpose of the Study:
- To review current concepts and management strategies for transient ischemic attacks (TIAs).
- To discuss the role of pharmacological interventions and surgery in stroke prevention post-TIA.
- To highlight the potential of multimodal and combination therapies for TIA patients.
Main Methods:
- Review of recent clinical trials and pharmacological data.
- Analysis of antiplatelet agents, warfarin, statins, ACE inhibitors, and estrogen replacement therapy.
- Evaluation of surgical interventions following TIAs.
Main Results:
- Newer antiplatelet agents offer advanced options for stroke prevention.
- Warfarin and other pharmacological agents play a crucial role in TIA management.
- Multimodal pharmacological approaches and combination therapy show significant patient benefit.
Conclusions:
- TIA management has evolved, incorporating a wider range of pharmacological options.
- Combination therapy represents a promising strategy for optimizing stroke prevention in TIA patients.
- A multimodal approach is essential for improving outcomes after transient cerebral ischemia.